MedTrace Logo

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

NCT06555289 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-12

No results posted yet for this study

Summary

This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.

Conditions

  • Cataract

Interventions

DEVICE

Clareon PanOptix Pro IOL

Spherical and toric T3

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Juliette Eye Institute Research Center

    lead OTHER

Principal Investigators

  • Robert Melendez, MD, MBA · Juliette Eye Institute Research Center

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-23
Primary Completion
2026-09-01
Completion
2026-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555289 on ClinicalTrials.gov